Physician profile
Robert P Cyr
NPI 1548466428
$5,137.92
in general payments reported to CMS, 2019-2025
29 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $147 · 2021: $488 · 2022: $808 · 2023: $412 · 2024: $2,325 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $888.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $2,057.84 | 2024 | Activ.A.C., V.A.C.Ulta |
| Smith+Nephew, INC. | $676.01 | 2019-2025 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Organogenesis INC. | $317.31 | 2019-2023 | Puraply |
| Medtronic Vascular, INC. | $246.39 | 2019-2020 | |
| Kci USA, INC. | $235.82 | 2019-2022 | |
| Stryker Corporation | $146.33 | 2019 | |
| Novo Nordisk INC | $136.81 | 2022 | |
| Kerecis Limited | $131.31 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $125.40 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2021 | |
| Bioventus LLC | $121.84 | 2022 | |
| Celularity INC. | $117.00 | 2019 | |
| Medline Industries LP | $112.48 | 2021-2023 | |
| Acera Surgical, INC. | $69.22 | 2019-2020 | |
| Integra Lifesciences Corporation | $63.97 | 2019-2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $61.84 | 2021 | |
| Convatec INC. | $52.43 | 2021-2023 | |
| Lilly USA, LLC | $44.86 | 2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $37.90 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Averitas Pharma INC. | $35.03 | 2024 | Qutenza |
| Urgo Medical North America, LLC | $31.30 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mannkind Corporation | $31.04 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $30.31 | 2025 | |
| Aimmune Therapeutics, INC. | $28.72 | 2025 | Vowst |
| Pfizer INC. | $24.74 | 2024 | |
| Philips North America LLC | $23.48 | 2024 | (Ck6) Holter |
| Si-Bone, INC. | $19.20 | 2022 | |
| Medela LLC | $17.95 | 2019 | |
| Galderma Laboratories, L.P. | $16.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cyr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.